A cell death program–based tumor signature stratifies prognosis, immune landscape, and therapeutic response in glioma - Poll - MDSpire

A cell death program–based tumor signature stratifies prognosis, immune landscape, and therapeutic response in glioma

  • By

  • Zhang, Huaichao

  • Yang, Zijiang

  • Xie, Qiang

  • Chen, Pin

  • Huang, Jinlong

  • Liu, Shuang

  • Li, Zeyang

  • Sun, Wei

  • Zhang, Xiaobiao

  • Xie, Tao

  • May 4, 2026

  • 0 min

Share

Original Source(s)

A cell death program–based tumor signature stratifies prognosis, immune landscape, and therapeutic response in glioma

  • by Zhang, Huaichao , Yang, Zijiang , Xie, Qiang , Chen, Pin , Huang, Jinlong , Liu, Shuang , Li, Zeyang , Sun, Wei , Zhang, Xiaobiao , Xie, Tao

  • May 4, 2026

Related Content

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”